MaaT Pharma
Phase 2We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $106.8M
About
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
BiologicsMicrobiome
Funding History
4Total raised:$106.8M
IPO$50MSep 23, 2021
Series B$34MJul 15, 2020
Series A$20MMar 15, 2018
Seed$2.8MSep 15, 2014